Single-Cell Fluidic Compartmentalization Using Degradable Polymer Matrices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing single-cell analysis methods face challenges in performing assays on individual cells without additional processing steps, such as nucleotide amplification, while preserving spatial information and avoiding cross-contamination.
Innovation Solution
A system comprising a fluidic device with polymer precursors and an energy source forms polymer matrices around biological components, allowing for compartmentalization and selective degradation of these matrices to combine or release targeted components, enabling assays without additional processing steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If single-cell analysis is performed without compartmentalization, then processing time is reduced, but cross-contamination between cells increases and spatial information is lost
Solution Approach 1:
The system divides the biological sample into discrete compartments using polymer matrices that encapsulate individual cells or cellular components. This segmentation allows parallel processing of multiple cells simultaneously while maintaining physical separation, thus reducing overall processing time without causing cross-contamination between cells.
Solution Approach 2:
The polymer matrix provides a localized environment for each cell with specific properties (porosity, degradation rate, chemical composition) tailored to the assay requirements. This local quality control enables different processing conditions for different cells while maintaining spatial information about their original positions.
2Measurement precision
If additional processing steps like nucleotide amplification are added, then assay sensitivity is improved, but processing time and complexity increase
Solution Approach 1:
The polymer matrix is designed to pre-concentrate target molecules (nucleotides, proteins, metabolites) from the cell into a small volume during the encapsulation process. This preliminary concentration step reduces the need for subsequent amplification steps, maintaining assay sensitivity while significantly reducing processing time.
Solution Approach 2:
The polymer matrix acts as an intermediary that facilitates direct detection of cellular components by providing a controlled release environment. The matrix can be designed to degrade at controlled rates, releasing concentrated analytes directly onto detection surfaces, thereby eliminating or reducing the need for traditional amplification steps.
3Stability of the object's composition
If polymer matrices are made highly stable, then compartmentalization is maintained during assays, but degradation and release of contents becomes difficult
Solution Approach 1:
The polymer matrix incorporates degradation-triggering functional groups that respond to specific parameter changes (pH, temperature, light, enzymatic activity). The matrix remains stable under assay conditions but undergoes controlled degradation when exposed to the appropriate trigger, enabling easy release of contents without compromising compartmental integrity during the assay.
Solution Approach 2:
The polymer matrix transitions from a static, stable structure during the assay to a dynamic, degradable structure upon stimulation. This dynamic behavior allows the matrix to maintain compartmentalization when needed and facilitate content release when required, improving ease of operation without sacrificing stability during the critical assay period.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system efficiently processes individual biological components with retained spatial information, reducing cross-contamination and processing time, while maintaining high data quality and resolution.
Implementation Method 1
the at least one energy source supplies energy to the fluidic device to cause the one or more polymer precursors to form at least one polymer matrix on or adjacent to the biological component
Implementation Method 2
the gel structures are degradable. In further embodiments, degrading at least part of at least two adjacent gel structures allows the contents of the at least the two adjacent gel structures to be combined
Data Source
AI summary
Systems for analyzing biological components are provided. The systems may include a fluidic device and an energy source in communication with the fluidic device. The energy source may supply energy to the fluidic device to form a polymer matrix on or adjacent to a biological component within the fluidic device. Methods of using the systems to analyze biological components are also provided.